Antidepressant drugs given repeatedly change the binding of the dopamine D 2 receptor agonist, [ 3 H]N-0437, to dopamine D 2 receptors in the rat brain

By Maj J.   Dziedzicka-Wasylewska M.   Rogoz R.   Rogoz Z.   Skuza G.  

European Journal of Pharmacology, Vol. 304, Iss. 1, 1996-05 ,pp. : 49-54

Elsevier

Access to resources Recommend Favorite

Synthesis and evaluation of cis-1-methyl-3-n-propyl-2,3,3a,4,5,9b-hexahydro-1H-benz[e]indoles for in vitro dopamine D 1 and D 2 receptor binding affinity

By Ghosh D.   Klein C.   Garner B.   Andersen P.   Crider A.  

European Journal of Medicinal Chemistry, Vol. 30, Iss. 12, 1995-01 ,pp. : 943-948

Elsevier

Access to resources Recommend Favorite

Cardiovascular effects produced by R-(+)-8-hydroxy-2-(di-n-propylamino) tetralin in the preoptic area of conscious rats

By Szabo A.   Bowman M.   Braun C.J.   Alper R.H.  

European Journal of Pharmacology, Vol. 315, Iss. 2, 1996-11 ,pp. : 187-194

Elsevier

Access to resources Recommend Favorite

Differential effects of (R)- and (S)-8-hydroxy-2-(di-n-propylamino)tetralin on the monosynaptic spinal reflex in rats

By Honda M.   Ono H.  

European Journal of Pharmacology, Vol. 373, Iss. 2, 1999-06 ,pp. : 171-179

Elsevier

Access to resources Recommend Favorite

Discriminative stimulus properties of S32504, a novel D₃/D₂ receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D₂ but not D₃ receptors

By Millan Mark   Iob Loretta   Péglion Jean-Louis   Dekeyne Anne  

Psychopharmacology, Vol. 191, Iss. 3, 2007-04 ,pp. : 767-782

Springer Publishing Company

Access to resources Recommend Favorite